Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors.

JCI Insight · 2021 · PMC8492342 · PMID 34283809

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

We found that the change in DC2 phenotype was not conserved outside the tumor, with only CD64 expression showing a decreasing trend while the other myeloid markers and Clec9a did not have any significant change ( Supplemental Figure 3 , B and C).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.